Interesting thoughts NZ!
Have you personally discarded alternate funding methods other than a CR?
I'm curious how you view the chances of ODD approval? From my reading, the benchmark doesn't seem all that high?
MT did suggest that the survival data alone may support ODD approval. That was prior to the outstanding ALS-FRS results based on the statistical analysis?
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1368
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $86.77M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.8¢ | 19.5¢ | $67.86K | 346.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 360690 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 792103 | 8 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |